29th Sep 2011 13:00
Regenersis plc
("Regenersis" or the "Company")
Director/PDMR Shareholding
Regenersis plc (the 'Company'), a strategic outsourcing partner to many of the world's leading consumer technology companies, received notification on 29 September 2011 of the following director dealing in the ordinary shares of 2 pence each in the Company ("Shares").
On 28 September 2011, Dauphin Capital LLC acquired 650,000 Shares. The purchase price of these shares was 84.3 pence per Share.
Matthew Peacock, Chairman of Regenersis, as a partner in Hanover Investors Management LLP, is a connected party to Dauphin Capital LLC. The combined resultant holding of Hanover Investors Management LLP and its connected parties is 7,765,608 ordinary shares equating to 17.33 per cent. of the issued share capital of the Company.
Enquiries:
Regenersis plc | +44 (0) 1865 471900 |
Jeremy Wilson | |
Arden Partners plc | +44 (0) 121 423 8900 |
Steve Douglas | |
FTI Consulting | +44 (0)20 7831 3113 |
Matt Dixon / Charles Palmer / Jon Snowball |
Ends
Related Shares:
BLTG.L